Clinical Trial

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 24, 2025 (before its estimated December 19, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the experience so far in dealing with the condition. This is a survey-based study; hence no medications or other treatments will be provided to participants as a part of this study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-02.
Trial Details
NCT Number NCT07163260
Lead Sponsor Novo Nordisk A/S
Conditions Haemophilia
Enrollment 244 participants
Start Date 2025-01-31
Primary Completion 2025-12-19 (estimated)
Study Completion 2025-12-19 (estimated)
Updated on ClinicalTrials.gov 2025-10-24